Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosis.
DLQI
HDSS
PROMs
QoL
bromhidrosis
energy based device
hyperhidrosis
microwave thermolysis
osmidrosis
patient reported outcome measures
Journal
Lasers in surgery and medicine
ISSN: 1096-9101
Titre abrégé: Lasers Surg Med
Pays: United States
ID NLM: 8007168
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
26
09
2022
received:
05
07
2022
accepted:
26
09
2022
pubmed:
15
10
2022
medline:
2
2
2023
entrez:
14
10
2022
Statut:
ppublish
Résumé
Microwave thermolysis (MWT) is an emerging treatment for axillary hyperhidrosis reducing both sweat and odor. No prior studies have investigated and compared the different available energy settings of the MWT device. This study evaluated patient-reported outcome measures (PROMs) for axillary hyperhidrosis and osmidrosis following MWT treatment with two different energy levels. Twenty adults with axillary hyperhidrosis and osmidrosis reported sweat on Hyperhidrosis Disease Severity scale (HDSS: 1-4) and odor on Odor scale (OS: 1-10), respectively, supplemented by overall Dermatology Life Quality Index (DLQI: 0-30). This was a prospective, randomized, patient-blinded and intraindividually controlled study with 3 months follow-up (FU). Randomization comprised MWT treatment of one axilla with a standard medium energy setting (energy level 3) and the contralateral axilla with a standard high energy setting (energy level 5). At baseline, patients reported substantial sweat and odor, negatively affecting their quality of life. At 3 months FU, PROMs showed improved quality of life with significantly reduced odor and sweat. Overall DLQI was reduced from a median of 10 to 4, with a median 6.5-point reduction (p = 0.0002). HDSS was reduced from a median of 4 to 2 on both sides, with a median reduction of 1 for medium energy level and 2 points for high energy level (p = 0.014). OS was reduced from a median of 8 to 3 for both energy levels, with a median reduction of 3.5 and 4.5 points for the medium and high energy level, respectively (p = 0.017). Local skin reactions were mild and transient, but slightly more pronounced following treatment with the high energy level. MWT effectively improved patients' quality of life, axillary sweat, and odor 3 months after on baseline treatment. Treatment with the high energy level presented a subtle but significant increase of efficacy based on PROMs for both sweat and odor. Patients were willing to accept a higher amount of temporary local skin reactions from a higher energy setting when experiencing greater odor and sweat reduction.
Identifiants
pubmed: 36229952
doi: 10.1002/lsm.23610
pmc: PMC10092657
doi:
Types de publication
Randomized Controlled Trial
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
105-115Informations de copyright
© 2022 The Authors. Lasers in Surgery and Medicine published by Wiley Periodicals LLC.
Références
Dermatol Surg. 2017 Apr;43(4):558-565
pubmed: 28005625
J Am Acad Dermatol. 2019 Sep;81(3):657-666
pubmed: 30710604
J Dermatolog Treat. 2022 Feb;33(1):420-426
pubmed: 32343164
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
Australas J Dermatol. 2017 May;58(2):126-129
pubmed: 26802036
J Cosmet Laser Ther. 2021 May 19;23(3-4):49-51
pubmed: 34409892
Actas Dermosifiliogr. 2017 Jun;108(5):418-422
pubmed: 28284421
Br J Dermatol. 2008 Nov;159(5):997-1035
pubmed: 18795920
J Cosmet Dermatol. 2019 Apr;18(2):594-601
pubmed: 30203579
Lasers Surg Med. 2023 Jan;55(1):105-115
pubmed: 36229952
J Cosmet Laser Ther. 2013 Oct;15(5):255-9
pubmed: 23713761
Lasers Surg Med. 2020 Nov;52(9):842-847
pubmed: 32175622
Dermatol Surg. 2012 May;38(5):728-35
pubmed: 22452511
Lasers Surg Med. 2021 Nov;53(9):1220-1226
pubmed: 34036606
Dermatol Clin. 2014 Oct;32(4):533-40
pubmed: 25152347
Lasers Surg Med. 2012 Jan;44(1):20-5
pubmed: 22127730
J Cosmet Laser Ther. 2017 Feb;19(1):36-42
pubmed: 27782761
Dermatol Surg. 2014 Apr;40(4):482-5
pubmed: 24438388
J Invest Dermatol. 2005 Oct;125(4):659-64
pubmed: 16185263
Dermatol Surg. 2014 Jul;40(7):805-7
pubmed: 24927005
Dermatol Surg. 2012 Feb;38(2):185-91
pubmed: 22289389
Lasers Surg Med. 2019 Sep;51(7):592-599
pubmed: 30811620
J Cosmet Laser Ther. 2017 Nov;19(7):439-441
pubmed: 28657370